StenoCare quarantines CannTrust unlicensed products
CannTrust, which describes itself as the "primary" supplier of medical cannabis, voluntarily halted all sales and shipments of this product after Health Canada discovered it was cultivating cannabis in five unlicensed theaters and after the department had received inaccurate information. On the other hand, the Danish company StenoCare announced on Thursday that it would quarantine batches of oil from its partner CannTrust from what the Canadian federal health regulator calls unlicensed facilities.
The company has also set up a special committee to investigate the matter. CannTrust is acting as a "precaution" as Health Canada investigates the company's facilities in Vaughan, Ont., A company statement said Thursday.
"CannTrust is working closely with the regulator throughout the review process and is planning to provide additional details on the duration of the hold and other developments as they become available," adds the press release.
The changes come after the company announced that it had suspended more than 5000kg of dried cannabis that had been grown on unlicensed premises at a facility in Pelham, Ont. between October 2018 and March 2019. Apparently the company had pending room requests with Health Canada at the time.
CannTrust announced Monday that it has suspended approximately 7500kg of dried cannabis equivalent at its Vaughan facility. This product had been manufactured on unlicensed premises in Pelham, CannTrust said.
The Ontario Cannabis Store said on Wednesday it was withdrawing some of its products from online sale and shipping to brick-and-mortar stores, following an investigation by Health Canada.
All customers who ordered a CannTrust product were eligible for a refund if the products were returned unopened within two weeks of delivery.
CannTrust serves more than 72000 medical patients with dried products, extracts and capsules. The company operates a harvest facility in Pelham and a manufacturing facility in Vaughan.
CannTrust products quarantined by a Danish company
Danish cannabis company StenoCare announced on Thursday it will quarantine more batches of cannabis oil
“The most likely consequence of this new situation is that there will be a temporary shortage of medicinal cannabis products on the Danish market,” StenoCare said in a statement. communicated.
StenoCare shares, which were listed in Stockholm in October 2018, fell by 30% early in the session before recovering and falling back around 8%.
Denmark legalized the medical use of cannabis as a testi and is also one of the few European countries to legalize local production. Recreational use is still prohibited, although Copenhagen's Christiania district is famous for its cannabis stalls, which are rarely targeted by authorities.
StenoCare could not specify how much of the cannabis oil in question had reached consumers but said all products had been tested and met the required health standards.
False walls at CannTrust to deceive Health Canada
according to TVA NouvellesThe Ontario cannabis producer laid false walls in one of its facilities to hide sections of plants that had not yet been approved by Health Canada, The Globe and Mail reported on Thursday.
CannTrust noted that the culture in unauthorized wards was waiting for a response to license applications filed with Health Canada. Permits were issued for each of the five rooms in April 2019.
CannTrust stock plunges after issues broke
CannTrust Holdings' stock fell on Monday as Health Canada determined that cannabis producer facilities in Pelham, Ontario, were not complying with certain regulations, which could lead to temporary product shortages.
The company said it takes the matter "very seriously". However, she declined to say whether senior management was aware of the scheme ordered by a greenhouse official. CannTrust has officially started the process of relocating "Trust" in "CannTrust".